Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00720785
Title Natural Killer Cells and Bortezomib to Treat Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Heart, Lung, and Blood Institute (NHLBI)
Indications

chronic lymphocytic leukemia

Ewing sarcoma

adenocarcinoma

pancreatic adenocarcinoma

chronic myeloid leukemia

colorectal cancer

lung non-small cell carcinoma

lung small cell carcinoma

renal cell carcinoma

multiple myeloma

prostate adenocarcinoma

melanoma

carcinoma

CLL/SLL

Therapies

Bortezomib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.